AI MARKET SCANNING

$VTGN

Vistagen Therapeutics Inc

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP-2.91%
MAX GAP RECORD-19.23%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $VTGN

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.7%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR $VTGN

AI REPORT
Aug 06

Deep Dive into VTGN: Parsing the Earnings Gap Anticipation

AnalysisMarkets are buzzing with anticipation as $VTGN prepares to release its quarterly earnings, setting the stage for potential…
VIEW REPORT_
AI REPORT
Aug 06

Daily Champions: Quant Insights on Selective Opportunities

Analysis Markets are undergoing a dynamic pivot as global sentiment shifts. The recent rout in $AI-driven equities, coupled…
VIEW REPORT_